Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective
出版年份 2016 全文链接
标题
Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective
作者
关键词
-
出版物
BRAIN PATHOLOGY
Volume 26, Issue 5, Pages 664-671
出版商
Wiley
发表日期
2016-06-23
DOI
10.1111/bpa.12399
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment
- (2016) Sepideh Shokouhi et al. Alzheimers Research & Therapy
- The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
- (2015) Mark E. Schmidt et al. Alzheimers & Dementia
- Measurement of Longitudinal -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios
- (2015) S. M. Landau et al. JOURNAL OF NUCLEAR MEDICINE
- Improved Power for Characterizing Longitudinal Amyloid- PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region
- (2015) K. Chen et al. JOURNAL OF NUCLEAR MEDICINE
- Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction
- (2015) Matthias Brendel et al. NEUROIMAGE
- Modeling clustered activity increase in amyloid-beta positron emission tomographic images with statistical descriptors
- (2015) Sepideh Shokouhi et al. Clinical Interventions in Aging
- The Alzheimer’s Prevention Initiative Composite Cognitive Test Score
- (2014) Napatkamon Ayutyanont et al. JOURNAL OF CLINICAL PSYCHIATRY
- Neural compensation in older people with brain amyloid-β deposition
- (2014) Jeremy A Elman et al. NATURE NEUROSCIENCE
- 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons
- (2014) David S. Knopman et al. NEUROBIOLOGY OF AGING
- Association of hypometabolism and amyloid levels in aging, normal subjects
- (2014) V. J. Lowe et al. NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Pathology of clinical and preclinical Alzheimer’s disease
- (2013) Dietmar Rudolf Thal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for -Amyloid Imaging in Aging and Dementia
- (2013) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- PET Quantification of 18F-Florbetaben Binding to -Amyloid Deposits in Human Brains
- (2013) G. A. Becker et al. JOURNAL OF NUCLEAR MEDICINE
- Longitudinal Progression of Cognitive Decline Correlates with Changes in the Spatial Pattern of Brain 18F-FDG PET
- (2013) S. Shokouhi et al. JOURNAL OF NUCLEAR MEDICINE
- Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden
- (2013) Rachel A. Yotter et al. NEUROBIOLOGY OF AGING
- Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [18F]AV-45 Positron Emission Tomography in Chinese Population
- (2013) Kuo-Lun Huang et al. PLoS One
- Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
- (2013) Benjamin Lam et al. Alzheimers Research & Therapy
- Blood-brain transfer of Pittsburgh compound B in humans
- (2013) Albert Gjedde et al. Frontiers in Aging Neuroscience
- Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer’s disease
- (2012) Karl Herholz Biomarkers in Medicine
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
- (2012) V. Camus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?
- (2012) P. Edison et al. NEUROIMAGE
- -Amyloid burden in healthy aging: Regional distribution and cognitive consequences
- (2012) K. M. Rodrigue et al. NEUROLOGY
- Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue
- (2011) Seok Rye Choi et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
- (2011) Clifford R. Jack et al. ANNALS OF NEUROLOGY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- PET amyloid-beta imaging in preclinical Alzheimer's disease
- (2011) Andrei G. Vlassenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Alzheimer's Disease: The Challenge of the Second Century
- (2011) D. M. Holtzman et al. Science Translational Medicine
- Technical aspects of amyloid imaging for Alzheimer's disease
- (2011) Paul Edison et al. Alzheimers Research & Therapy
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
- (2010) D. F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms
- (2010) Elaine R. Peskind et al. NEUROIMAGE
- Report of the task force on designing clinical trials in early (predementia) AD
- (2010) P. S. Aisen et al. NEUROLOGY
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
- (2009) Clifford R. Jack et al. BRAIN
- Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage
- (2009) A. Pezzini et al. CURRENT MEDICINAL CHEMISTRY
- Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region
- (2009) Koon-Pong Wong et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease
- (2009) Lisa Mosconi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy
- (2009) Seth Love Frontiers in Bioscience-Landmark
- Basal Cerebral Metabolism May Modulate the Cognitive Effects of A in Mild Cognitive Impairment: An Example of Brain Reserve
- (2009) A. D. Cohen et al. JOURNAL OF NEUROSCIENCE
- Reversible acute leukoencephalopathy as a form of presentation in cerebral amyloid angiopathy
- (2009) L.M. Cano et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
- (2009) Susan M. Landau et al. NEUROBIOLOGY OF AGING
- Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies
- (2009) Juergen Dukart et al. NEUROIMAGE
- Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
- (2009) Roy O Weller et al. Alzheimers Research & Therapy
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study
- (2008) Angelo Del Sole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18
- (2008) Igor Yakushev et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- PET imaging of amyloid deposition in patients with mild cognitive impairment
- (2007) Anton Forsberg et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search